High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s
Researchers have found that adults 65 and older who received a high-dose influenza vaccine had a significantly lower risk of developing Alzheimer’s disease compared to those who received the standard dose.
AREXVY RSV Vaccine Approved for Expanded Age Indication
The U.S. Food and Drug Administration has expanded the approved age indication of AREXVY to adults aged 18 to 49 years at increased risk for lower respiratory tract disease caused by RSV.
Researchers Discover Why a Rare Blood Clot Occurs After COVID-19 Vaccination
Researchers have discovered why the unusual side effect of a blood clot that impacted some recipients of the Oxford/AstraZeneca and Johnson & Johnson COVID-19 vaccines occurred.
Scientists Develop a Potential Universal Respiratory Vaccine
Stanford Medicine researchers have invented a new vaccine that protects mice from respiratory viruses, bacteria and allergens, which is the closest yet to a universal vaccine.
Vaccine Against SARS Virus Family Enters Human Clinical Trials
A vaccine candidate called GBP511 that builds upon a self-assembling nanoparticle technology has begun human clinical testing in Australia.
Breast Cancer Vaccine Study Shows Positive Results
A clinical tria that evaluated an alpha-lactalbumin (aLA) vaccine demonstrated an immune response in 74 percent of patients who presently have or are at high risk for triple-negative breast cancer.
Human Trials Begin for Fentanyl Vaccine to Prevent Overdoses
A vaccine that blocks the effects of fentanyl, including overdoses, is scheduled for Phase I human trials in the Netherlands in early 2026 to assess its safety.
Study Shows mRNA Vaccine Revitalizes the Immune System
Researchers have demonstrated that weakened immune systems of older individuals can be rejuvenated using mRNA technology to transform the liver in mice into a temporary source of immune regulatory factors that are naturally lost during aging.
CDC Approves Change to Nation’s Childhood Immunization Schedule
The Centers for Disease Control and Prevention has approved a change to the nation’s childhood immunization schedule to drop the long-standing practice of giving all newborns a hepatitis B vaccine within 24 hours of birth.
Huge Study Shows mRNA COVID Vaccines Associated with 25 Percent Lower Risk Of Death From Any Cause
In a national cohort study of 28 million individuals, researchers found no increased risk of four-year all-cause mortality in individuals aged 18 to 59 years vaccinated against COVID-19, further supporting the safety of the mRNA vaccines that are widely used worldwide.